Enovis
-
Biologics
Enovis™ and Ossium Health® Forge a Strategic Partnership to Expand the Distribution of OssiGraft™ and OssiGraft Prime™
A Strategic Partnership Set to Redefine Surgical Outcomes and Broaden Market Reach. WILMINGTON, DE, October 4, 2024 – Enovis™ (NYSE: ENOV),…
Read More » -
Recon
Enovis Appoints Tim Czartoski as President, U.S. Surgical and Global Product and Enabling Technologies
WILMINGTON, DE, Sept. 09, 2024 (GLOBE NEWSWIRE) — Enovis™ (NYSE: ENOV), an innovation-driven medical technology growth company, is pleased to…
Read More » -
Extremities
Enovis™ Introduces STAR® Ankle, now with e+™ Polyethylene for Unmatched Durability
Revolutionary Scandinavian Total Ankle Replacement (STAR® Ankle) System Now Includes Vitamin E-Blended Polyethylene Insert WILMINGTON, DE, August 19, 2024 – Enovis™…
Read More » -
Recon
Enovis™ Releases AltiVate Reverse® Glenoid System, Widening Range of Patients Who May be Treated with AltiVate Reverse®
New Full-Range Solution Adds Bone-Sparing Baseplate, Peripheral Fixation and Glenosphere Options to Proven Reverse Shoulder Prosthesis (RSP®) Glenoid Baseplate While…
Read More » -
Financial
Enovis Completes Acquisition of LimaCorporate S.p.A
WILMINGTON, Del., Jan. 03, 2024 (GLOBE NEWSWIRE) — Enovis™ Corporation (NYSE: ENOV, “Enovis” or the “Company”) an innovation-driven, medical technology…
Read More » -
Recon
Enovis Announces Business Segment Leadership Transition Plan
Brady R. Shirley, current President and COO, to retire effective April 1, 2025. Louie Vogt to be promoted to Group…
Read More » -
Financial
Enovis to Acquire LimaCorporate S.p.A.
Creating a high-growth, global reconstruction leader with ~$1 billion in annual revenue Attractive margin profile and meaningful synergies expected to increase profitability Wilmington, DE, Sept. 25, 2023 (GLOBE NEWSWIRE) —…
Read More » -
Extremities
Enovis™ Continues Expansion of Foot & Ankle Portfolio with Knotless Syndesmotic Repair System
Introducing Enofix™ with Constrictor® Technology; featuring a patented self-locking design to assist with ligament repair Wilmington, DE, April 11, 2023 –…
Read More » -
Extremities
Enovis to Acquire Novastep
Strengthens Foot and Ankle Portfolio with Leading Minimally Invasive Surgery (MIS) Platform, including MIS Bunion System and Furthers Global Expansion…
Read More » -
Extremities
Enovis Expands Foot & Ankle Portfolio’s DynaClip® Family by Introducing Procedure-Specific Staples
Innovative new staples combine strength with unmatched, sustained dynamic compression for mid-foot and first MTP joint fusions. Wilmington, DE, Jan.…
Read More » -
Extremities
Enovis Receives FDA Approval of Patient Specific Instrumentation for STAR® Ankle
Wilmington, DE, Dec. 01, 2022 (GLOBE NEWSWIRE) — Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology company, announced that the U.S. Food and Drug Administration…
Read More » -
Extremities
Enovis Announces Exclusive Agency Agreement with UK Orthopedic Leader Osteotec. Partnership expands Enovis’ fast-growing business in the UK and Ireland
GUILDFORD, Surrey, November 23, 2022 – Enovis Corporation, an innovation-driven medical technology company, announced an exclusive partnership with Osteotec, a…
Read More » -
Extremities
Enovis Introduces DynaNail Helix™ – a New Twist on Hindfoot Fusions
Designed with our patented and proven NiTiNOL technology, DynaNail Helix™ revolutionizes dynamic compression in foot & ankle fusion. Wilmington, DE,…
Read More » -
Recon
Enovis Launches ARVIS®, Only Augmented Reality Surgical Guidance System Designed Specifically to Improve Both Total Hip and Knee Replacement Surgery
ARVIS offers orthopedic surgeons a wearable AR headset used during surgery to help accurately place hip and knee implants July…
Read More » -
Extremities
Enovis™, Formerly Branded DJO®, Introduces Arsenal Ankle Plating System™
A comprehensive ankle plating portfolio, designed with the proven technology of Arsenal Foot Plating System, expands offerings to address both…
Read More »